Wave Life Sciences (WVE) Preferred Stock Liabilities (2016 - 2025)
Wave Life Sciences (WVE) has disclosed Preferred Stock Liabilities for 11 consecutive years, with $7.9 million as the latest value for Q4 2025.
- For Q4 2025, Preferred Stock Liabilities changed 0.0% year-over-year to $7.9 million; the TTM value through Dec 2025 reached $7.9 million, changed 0.0%, while the annual FY2025 figure was $7.9 million, 0.0% changed from the prior year.
- Preferred Stock Liabilities hit $7.9 million in Q4 2025 for Wave Life Sciences, roughly flat from $7.9 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $7.9 million in Q1 2021 and bottomed at $7.9 million in Q1 2021.
- Average Preferred Stock Liabilities over 5 years is $7.9 million, with a median of $7.9 million recorded in 2021.
- On a YoY basis, Preferred Stock Liabilities climbed as much as 0.0% in 2021 and fell as far as 0.0% in 2021.
- Wave Life Sciences' Preferred Stock Liabilities stood at $7.9 million in 2021, then changed by 0.0% to $7.9 million in 2022, then changed by 0.0% to $7.9 million in 2023, then changed by 0.0% to $7.9 million in 2024, then changed by 0.0% to $7.9 million in 2025.
- According to Business Quant data, Preferred Stock Liabilities over the past three periods came in at $7.9 million, $7.9 million, and $7.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.